Literature DB >> 17675341

Stability of soluble adhesion molecules, selectins, and C-reactive protein at various temperatures: implications for epidemiological and large-scale clinical studies.

Janine Hartweg1, Michael Gunter, Rafael Perera, Andrew Farmer, Carole Cull, Casper Schalkwijk, Astrid Kok, Harry Twaalfhoven, Rury Holman, Andrew Neil.   

Abstract

BACKGROUND: We assessed the impact of sample storage conditions on soluble vascular cell adhesion molecules (sVCAM), soluble intracellular adhesion molecules (sICAM-1), soluble (s)E-selectin, C-reactive protein (CRP), and sP-selectin.
METHODS: Markers were measured by ELISA in venous blood from 10 healthy volunteers on aliquots stored as plasma or whole blood at 4, 21, or 30 degrees C for 1-5 days and after 1-5 freeze-thaw cycles. We compared results on these samples to results for samples processed immediately and stored at -80 degrees C. Statistical models assessed time-related effects and effects of postprocessing conditions.
RESULTS: Using an upper limit of 10% variation from baseline with P >0.05, we found that stability duration in plasma was 5 days for sVCAM-1 and sICAM-1 and at least 2 days for sE-selectin at 4, 21, and 30 degrees C and 5 days for CRP at 4 and 21 degrees C and 1 day at 30 degrees C. Stability duration in whole blood was 5 days for sVCAM-1 and sICAM-1 and at least 2 days for sE-selectin at 4, 21, and 30 degrees C and 5 days for CRP at 4 and 21 degrees C and 2 days at 30 degrees C. sP-selectin was not stable in plasma or whole blood. sICAM-1, sVCAM-1, CRP, and sE-selectin were stable after 5 freeze-thaw cycles.
CONCLUSIONS: sVCAM-1, sICAM-1, and CRP are stable in plasma or whole blood at 4 and 21 degrees C for at least 3 days and sE-selectin for 2 days. sP-selectin is not stable and therefore requires immediate assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675341     DOI: 10.1373/clinchem.2006.076380

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Vitamin D status and early age-related macular degeneration in postmenopausal women.

Authors:  Amy E Millen; Rick Voland; Sherie A Sondel; Niyati Parekh; Ronald L Horst; Robert B Wallace; Gregory S Hageman; Rick Chappell; Barbara A Blodi; Michael L Klein; Karen M Gehrs; Gloria E Sarto; Julie A Mares
Journal:  Arch Ophthalmol       Date:  2011-04

2.  Effects of Transport Temperature on the Stability of Inflammatory, Hemostasis, Endothelial Function, and Oxidative Stress Plasma Biomarker Concentrations.

Authors:  Octavia M Peck Palmer; Melinda Carter; Chung-Chou H Chang; Nicole Lucko; Vanessa M Jackson; Qian Sun; Xinyan Xie; Melanie Scott; John A Kellum; Arvind Venkat; Sachin Yende
Journal:  Shock       Date:  2017-06       Impact factor: 3.454

Review 3.  Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?

Authors:  Montserrat Serra-Millàs
Journal:  World J Psychiatry       Date:  2016-03-22

4.  Temporal reliability of cytokines and growth factors in EDTA plasma.

Authors:  Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Annika Idahl; Göran Hallmans; Karen L Koenig; Adele M Marrangoni; Brian M Nolen; Nina Ohlson; Anne Zeleniuch-Jacquotte; Eva Lundin
Journal:  BMC Res Notes       Date:  2010-11-13

5.  Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients.

Authors:  Stuart McGrane; Timothy D Girard; Jennifer L Thompson; Ayumi K Shintani; Alison Woodworth; E Wesley Ely; Pratik P Pandharipande
Journal:  Crit Care       Date:  2011-03-02       Impact factor: 9.097

6.  Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study.

Authors:  Setor K Kunutsor; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Atheroscler Thromb       Date:  2017-02-16       Impact factor: 4.928

7.  A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy.

Authors:  Susan M Graham; Nimerta Rajwans; Kenneth A Tapia; Walter Jaoko; Benson B A Estambale; R Scott McClelland; Julie Overbaugh; W Conrad Liles
Journal:  BMC Infect Dis       Date:  2013-06-04       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.